COV Stock Analysis: Covivio | PA
REIT - Diversified | PA, France | Market Cap: 6.109m EUR | 12M Return: 5.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.21M
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Covivio SA is a French real estate company operating at a European scale, focused on combining working, traveling, and living spaces by engaging closely with end users. The company manages €23.7 billion in assets and serves businesses, hotel operators, and territorial authorities, supporting their needs around attractiveness, transformation, and responsible performance. Incorporated in 1963 and listed on Euronext Paris (COV), Covivio operates as a diversified REIT, meaning it generates income from multiple property types including offices, residential, and hospitality assets rather than concentrating on a single segment. The company emphasizes a stakeholder-oriented business model, positioning real estate as a driver of well-being and long-term urban value creation.
- ECB rate cuts ease refinancing pressure on portfolio debt
- Office occupancy recovery in Paris and Milan lifts rental income
- German residential rent caps constrain revenue growth
| Net Income: 738.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.84 > 1.0 |
| NWC/Revenue: -64.71% < 20% (prev -7.07%; Δ -57.65% < -1%) |
| CFO/TA 0.03 > 3% & CFO 708.3m > Net Income 738.7m |
| Net Debt (10.0b) to EBITDA (1.45b): 6.93 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (110.8m) vs 12m ago 10.65% < -2% |
| Gross Margin: 41.67% > 18% (prev 62.87%; Δ -21.19% > 0.5%) |
| Asset Turnover: 4.23% > 50% (prev 4.50%; Δ -0.26% > 0%) |
| Interest Coverage Ratio: 3.85 > 6 (EBIT TTM 1.30b / Interest Expense TTM 338.1m) |
| A: -0.03 (Total Current Assets 1.21b - Total Current Liabilities 1.90b) / Total Assets 25.3b |
| B: 0.03 (Retained Earnings 738.7m / Total Assets 25.3b) |
| C: 0.05 (EBIT TTM 1.30b / Avg Total Assets 25.1b) |
| D: 0.68 (Book Value of Equity 8.61b / Total Liabilities 12.7b) |
| Altman-Z'' = 0.98 = BB |
| DSRI: 0.91 (Receivables 330.5m/382.0m, Revenue 1.06b/1.12b) |
| GMI: 1.51 (GM 62.87% / 41.67%) |
| AQI: 1.06 (AQ_t 0.87 / AQ_t-1 0.83) |
| SGI: 0.95 (Revenue 1.06b / 1.12b) |
| TATA: 0.00 (NI 738.7m - CFO 708.3m) / TA 25.3b) |
| Beneish M = -2.64 (Cap -4..+1) = A |
As of July 05, 2026, the stock is trading at EUR 54.20 with a total of 79,363 shares traded. Over the past week, the price has changed by -1.72%, over one month by +1.78%, over three months by +1.21% and over the past year by +5.30%.
Current recommended Stop Loss: 51.80 (which is 4.4% or 2.1 ATR below the current price).
Covivio has no consensus analysts rating.
P/E Trailing = 8.3183
P/E Forward = 10.9409
P/S = 5.3305
P/B = 0.7009
P/EG = 24.6239
Revenue TTM = 1.06b EUR
EBIT TTM = 1.30b EUR
EBITDA TTM = 1.45b EUR
Long Term Debt = 8.66b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.98b EUR (from shortTermDebt, last quarter)
Debt = 11.2b EUR (from shortLongTermDebtTotal, last quarter) + Leases 304.4m
Net Debt = 10.0b EUR (calculated: Debt 11.2b - CCE 1.21b)
Enterprise Value = 16.1b EUR (6.11b + Debt 11.2b - CCE 1.21b)
Interest Coverage Ratio = 3.85 (Ebit TTM 1.30b / Interest Expense TTM 338.1m)
EV/FCF = 125.4x (Enterprise Value 16.1b / FCF TTM 128.7m)
FCF Yield = 0.80% (FCF TTM 128.7m / Enterprise Value 16.1b)
FCF Margin = 12.10% (FCF TTM 128.7m / Revenue TTM 1.06b)
Net Margin = 69.47% (Net Income TTM 738.7m / Revenue TTM 1.06b)
Gross Margin = 41.67% ((Revenue TTM 1.06b - Cost of Revenue TTM 620.2m) / Revenue TTM)
Gross Margin QoQ = -2.96% (prev 62.50%)
Tobins Q-Ratio = 0.64 (Enterprise Value 16.1b / Total Assets 25.3b)
Interest Expense / Debt = 3.01% (Interest Expense 338.1m / Debt 11.2b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = 977.1m (EBIT 1.30b * (1 - 25.00%))
Current Ratio = 0.64 (Total Current Assets 1.21b / Total Current Liabilities 1.90b)
Debt / Equity = 1.30 (Debt 11.2b / totalStockholderEquity, last quarter 8.61b)
Debt / EBITDA = 6.93 (Net Debt 10.0b / EBITDA 1.45b)
Debt / FCF = 77.96 (Net Debt 10.0b / FCF TTM 128.7m)
Total Stockholder Equity = 8.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.94% (Net Income 738.7m / Total Assets 25.3b)
RoE = 8.90% (Net Income TTM 738.7m / Total Stockholder Equity 8.30b)
RoCE = 7.68% (EBIT 1.30b / Capital Employed (Equity 8.30b + L.T.Debt 8.66b))
RoIC = 3.85% (NOPAT 977.1m / Invested Capital 25.4b)
WACC = 3.78% (E(6.11b)/V(17.3b) * Re(6.59%) + D(11.2b)/V(17.3b) * Rd(3.01%) * (1-Tc(0.25)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 7.44%
[DCF] Terminal Value 73.10% ; FCFF base≈211.6m ; Y1≈185.6m ; Y5≈150.0m
[DCF] Fair Price = N/A (negative equity: EV 2.41b - Net Debt 10.0b = -7.63b; debt exceeds intrinsic value)
EPS Correlation: 39.99 | EPS CAGR: 38.06% | SUE: N/A | # QB: 0
Revenue Correlation: 37.04 | Revenue CAGR: 6.57% | SUE: 0.21 | # QB: 0
EPS current Year (2026-12-31): EPS=4.94 | Chg30d=-0.03% | Revisions=+0% | GrowthEPS=+8.1% | GrowthRev=+45.0%
EPS next Year (2027-12-31): EPS=5.04 | Chg30d=-0.20% | Revisions=+0% | GrowthEPS=+2.1% | GrowthRev=+18.2%
[Analyst] Revisions Ratio: +0% (up=0, down=0)